{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/29/3303496/31990/en/Agios-Provides-Update-on-Phase-2b-Trial-of-Tebapivat-in-Lower-Risk-Myelodysplastic-Syndromes.html", "message": "News view counter 766595 successfully enlarged"}